These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29672630)

  • 1. Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes.
    Wright T; Li A; Lotterhand J; Graham AR; Huang Y; Avila N; Pan J
    PLoS One; 2018; 13(4):e0195186. PubMed ID: 29672630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intrathecal recombinant arylsulfatase A therapy on structural brain magnetic resonance imaging in children with metachromatic leukodystrophy.
    Groeschel S; Beerepoot S; Amedick LB; Krӓgeloh-Mann I; Li J; Whiteman DAH; Wolf NI; Port JD
    J Inherit Metab Dis; 2024 Jul; 47(4):778-791. PubMed ID: 38321717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial.
    Í Dali C; Sevin C; Krägeloh-Mann I; Giugliani R; Sakai N; Wu J; Wasilewski M
    Mol Genet Metab; 2020; 131(1-2):235-244. PubMed ID: 32792226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study.
    Í Dali C; Groeschel S; Moldovan M; Farah MH; Krägeloh-Mann I; Wasilewski M; Li J; Barton N; Krarup C
    Ann Clin Transl Neurol; 2021 Jan; 8(1):66-80. PubMed ID: 33332761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
    Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
    J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
    Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
    Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of pH-dependent self-association of a recombinant form of arylsulfatase A with electrospray ionization mass spectrometry and size-exclusion chromatography.
    Abzalimov RR; Bobst CE; Salinas PA; Savickas P; Thomas JJ; Kaltashov IA
    Anal Chem; 2013 Feb; 85(3):1591-6. PubMed ID: 23252501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy.
    Matzner U; Lüllmann-Rauch R; Stroobants S; Andersson C; Weigelt C; Eistrup C; Fogh J; D'Hooge R; Gieselmann V
    Mol Ther; 2009 Apr; 17(4):600-6. PubMed ID: 19174759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK-611) in Children With Metachromatic Leukodystrophy.
    Troy S; Wasilewski M; Beusmans J; Godfrey CJ
    Clin Pharmacol Ther; 2020 Jun; 107(6):1394-1404. PubMed ID: 31868225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
    Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
    Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific analysis of N-linked oligosaccharides of recombinant lysosomal arylsulfatase A produced in different cell lines.
    Schröder S; Matthes F; Hyden P; Andersson C; Fogh J; Müller-Loennies S; Braulke T; Gieselmann V; Matzner U
    Glycobiology; 2010 Feb; 20(2):248-59. PubMed ID: 19864504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylsulfatases A and B in EBV-transformed lymphoid cell lines: studies on their molecular forms in cells from patients with inborn sulfatase deficiencies. Comparative diagnostic value of enzymatic assays.
    Tempesta MC; Levade T; Salvayre R
    Clin Chim Acta; 1991 Oct; 202(3):149-65. PubMed ID: 1687673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
    Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
    Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
    Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of recombinant human arylsulfatase A and leukocyte sulfatase activities by analytical isotachophoresis.
    Pajarola S; Weißenberg C; Baysal F; Bruchelt G; Krägeloh-Mann I; Böhringer J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():109-113. PubMed ID: 31195190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy.
    Stevens RL; Fluharty AL; Kihara H; Kaback MM; Shapiro LJ; Marsh B; Sandhoff K; Fischer G
    Am J Hum Genet; 1981 Nov; 33(6):900-6. PubMed ID: 6119902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Matzner U; Matthes F; Herbst E; Lüllmann-Rauch R; Callaerts-Vegh Z; D'Hooge R; Weigelt C; Eistrup C; Fogh J; Gieselmann V
    Mol Med; 2007; 13(9-10):471-9. PubMed ID: 17660863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapy.
    Martino S; Consiglio A; Cavalieri C; Tiribuzi R; Costanzi E; Severini GM; Emiliani C; Bordignon C; Orlacchio A
    J Biotechnol; 2005 May; 117(3):243-51. PubMed ID: 15862354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple molecular forms of arylsulfatase A in different forms of metachromatic leukodystrophy (MLD).
    Farrell DF; MacMartin MP; Clark AF
    Neurology; 1979 Jan; 29(1):16-20. PubMed ID: 34126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late juvenile metachromatic leukodystrophy (MLD) in three patients with a similar clinical course and identical mutation on one allele.
    Tylki-Szymanska A; Berger J; Löschl B; Lugowska A; Molzer B
    Clin Genet; 1996 Nov; 50(5):287-92. PubMed ID: 9007312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.